The effects of bone remodeling inhibition by alendronate on three-dimensional microarchitecture of subchondral bone tissues in guinea pig primary osteoarthrosis.

scientific article published on 4 January 2008

The effects of bone remodeling inhibition by alendronate on three-dimensional microarchitecture of subchondral bone tissues in guinea pig primary osteoarthrosis. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00223-007-9093-2
P698PubMed publication ID18175032

P50authorMing DingQ57078997
P2093author name stringCarl Christian Danielsen
Ivan Hvid
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)77-86
P577publication date2008-01-04
P1433published inCalcified Tissue InternationalQ5018771
P1476titleThe effects of bone remodeling inhibition by alendronate on three-dimensional microarchitecture of subchondral bone tissues in guinea pig primary osteoarthrosis
P478volume82

Reverse relations

cites work (P2860)
Q41810542Biological activities of phosphocitrate: a potential meniscal protective agent
Q59285534Characterization of Subchondral Bone Repair for Marrow-Stimulated Chondral Defects and Its Relationship to Articular Cartilage Resurfacing
Q64109275Combining naproxen and a dual amylin and calcitonin receptor agonist improves pain and structural outcomes in the collagen-induced arthritis rat model
Q35794592Disease-modifying effects of phosphocitrate and phosphocitrate-β-ethyl ester on partial meniscectomy-induced osteoarthritis
Q35164621Effect of alendronate on post-traumatic osteoarthritis induced by anterior cruciate ligament rupture in mice.
Q50454766Effects of bisphosphonates on osteogenesis and osteoclastogenesis signaling during the endochondral ossification of growing rats.
Q83390549Enhancement of subchondral bone quality by alendronate administration for the reduction of cartilage degeneration in the early phase of experimental osteoarthritis
Q34694718Expression of phosphocitrate-targeted genes in osteoarthritis menisci
Q37812618Microarchitectural adaptations in aging and osteoarthrotic subchondral bone issues.
Q44210916No effect of risedronate on articular cartilage damage in the Dunkin Hartley guinea pig model of osteoarthritis.
Q42019123Phosphocitrate is potentially a disease-modifying drug for noncrystal-associated osteoarthritis
Q43236606Positive effect of alendronate on subchondral bone healing and subsequent cartilage repair in a rabbit osteochondral defect model
Q47145743Protective effect of zoledronic acid on articular cartilage and subchondral bone of rabbits with experimental knee osteoarthritis
Q46147877Relationship between articular cartilage damage and subchondral bone properties and meniscal ossification in the Dunkin Hartley guinea pig model of osteoarthritis
Q28552506Sodium Thiosulfate Prevents Chondrocyte Mineralization and Reduces the Severity of Murine Osteoarthritis
Q90366914Subchondral bone osteoclasts induce sensory innervation and osteoarthritis pain
Q42181185Subchondral bone plate thickening precedes chondrocyte apoptosis and cartilage degradation in spontaneous animal models of osteoarthritis
Q37596611Targeting subchondral bone for treating osteoarthritis: what is the evidence?
Q34168273The OARSI histopathology initiative – recommendations for histological assessments of osteoarthritis in the guinea pig